Related Experiment Video

Updated: Feb 21, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

Potential Antitumor Effects of Pomegranates and Its Ingredients

Arshad H Rahmani1, Mohammed A Alsahli1, Saleh A Almatroodi1

  • 1Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.

Pharmacognosy Reviews
|October 10, 2017
PubMed

Insights

Pomegranates show significant anti-cancer properties, inhibiting tumor growth by modulating key cell signaling pathways. This review explores the anti-tumor mechanisms of pomegranate components for cancer therapy.

Area of Science:

  • Phytochemistry
  • Oncology
  • Molecular Biology

Background:

  • Plant-derived compounds offer a promising avenue for cancer treatment.
  • Medicinal plants and their constituents can modulate cell signaling and inhibit carcinogenesis.
  • Pomegranates, rich in antioxidants, exhibit cancer-preventive properties.

Purpose of the Study:

  • To review the anti-tumor activities of pomegranates and their components.
  • To elucidate the mechanisms of pomegranate action in cancer therapy.
  • To understand how pomegranate extracts modulate cancer cell signaling pathways.

Main Methods:

  • Literature review of studies on pomegranate's anti-cancer effects.
  • Analysis of research on pomegranate components and extracts.
  • Examination of evidence for pomegranate's impact on cell signaling pathways.

Main Results:

  • Pomegranates exhibit anti-tumor activities through various mechanisms.
  • Pomegranate components modulate cell signaling pathways, including transcription factors, apoptosis, and angiogenesis.
  • Antioxidant properties contribute to the cancer-preventive role of pomegranates.

Conclusions:

  • Pomegranates possess significant anti-tumor potential.
  • Understanding pomegranate's mechanisms can aid in developing novel cancer therapies.
  • Further research into pomegranate-based cancer treatments is warranted.
Keywords:
Antioxidantanti-tumorbioavailabilitycell signaling pathwayspomegranates

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

734
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K